Mohan RR et al.Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration.Mol Vis 22:1280-1290 (2016).
Nakamura A et al.Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog.Sci Rep 3:2183 (2013).
Birke K et al.Topical Application of PPADS Inhibits Complement Activation and Choroidal Neovascularization in a Model of Age-Related Macular Degeneration.PLoS One 8:e76766 (2013).
Trebicka E et al.Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.Clin Vaccine Immunol 20:1491-8 (2013).
Lorenz N et al.Full functional activity of SSL7 requires binding of both complement C5 and IgA.Immunol Cell Biol 91:469-76 (2013).
Ekser B et al.Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs.PLoS One 7:e29720 (2012).
Ma KN et al.Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.Invest Ophthalmol Vis Sci 51:6776-83 (2010).
Roos A et al.Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.J Am Soc Nephrol 17:1724-34 (2006).
Leaderer D et al.Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.J Gene Med 17:101-15 (0).